1,897
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one–linked to triazole moieties as potent cytotoxic agents

, , , &
Pages 1111-1119 | Received 17 May 2017, Accepted 15 Jun 2017, Published online: 09 Aug 2017

References

  • Nair RV, Fisher EP, Safe SH, et al. Novel coumarins as potential anticarcinogenic agents. Carcinogenesis 1991;12:65–9.
  • Wang P, Xia Y, Yu Y, et al. synthesis and biological evaluation of esculetin derivatives as anti-tumour agents. RSC Adv 2015;5:53477–83.
  • Zhou K, Wang YD, Dong W, et al. A new coumarin from roots of Angelica sinensis and its cytotoxicity. Chin Tradit Herbal Drugs 2015;46:2680–2.
  • Omaima MAH, Kamellia MA, A. Nehad AL. Synthesis and antitumor activity of some new xanthotoxin derivatives. Eur J Med Chem 2009;44:2967–74.
  • Saeed E, Sakineh D. Current developments of coumarin-based anti-cancer agents in medicinal chemistry. Eur J Med Chem 2015;102:611–30.
  • Ducharme Y, Blouin M, Brideau C. The discovery of setileuton, a potent and selective 5-lipoxygenase inhibitor. ACS Med Chem Lett 2010;1:170–4.
  • Kong Y, Fu YJ, Zu YG. Cajanuslactone, a new coumarin with anti-bacterial activity from pigeon pea [Cajanus cajan (L.) Millsp.] leaves. Food Chem 2010;121:1150–5.
  • Canning C, Sun S, Ji XM. Antibacterial and cytotoxic activity of isoprenylated coumarin mammea A/AA isolated from Mammea africana. J Ethnopharmacol 2013;147:259–62.
  • Magda MFI, Heba SR, Mohammad MMH. Synthesis and dockingstudies of novel benzopyran-2-ones with anticancer activity. Eur J Med Chem 2010;45:3950–9.
  • Lo´pez-Pe´rez JL, Olmedo DA, Olmo ED, et al. Cytotoxic 4-phenylcoumarins from the leaves of Marila pluricostata. J Nat Prod 2005;68:369–73.
  • Veselinović JB, Veselinović AM, Vitnik ŽJ. Antioxidant properties of selected 4-phenyl hydroxycoumarins: integrated in vitro and computational studies. Chem Biol Interact 2014;214:49–56.
  • Combes S, Barbier P, Douillard S. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins. Part 2. J Med Chem 2011;54:3153–62.
  • Roy SK, Kumari N, Pahwa S. NorA efflux pump inhibitory activity of coumarins from Mesua ferrea. Fitoterapia 2013;90:140–50.
  • Sheng C, Che X, Wang W, et al. Design and synthesis of novel triazole antifungal derivatives by structure-based bioisosterism. Eur J Med Chem 2011;46:5276–82.
  • Al-Soud YA, Al-Masoudi NA, Loddo R, et al. Antimycobacterial and antimicrobial study of new 1,2,4-triazoles with benzothiazoles. Arch Pharm (Weinheim) 2010;343:692–9.
  • Wang SB, Deng XQ, Zheng Y, et al. Synthesis and anticonvulsant activity evaluation of 8-alkoxy-5-(4H-1,2,4-triazol-4-yl)quinoline derivatives. Arch Pharm Res 2013;36:32–40.
  • Mathew V, Giles D, Keshavayya J, et al. Studies on synthesis and pharmacological activities of 1,2,4-triazolo[3,4-b]1,3,4-thiadiazoles and their dihydro analogues. Arch Pharm (Weinheim) 2009;342:210–12.
  • Lesyk R, Vladzimirska O, Holota S, et al. New 5-substituted thiazolo[3,2-b][1,2,4]triazol-6-ones: synthesis and anticancer evaluation. Eur J Med Chem 2007;42:641–8.
  • Song ZD, Liu YC, Dai ZT, et al. Synthesis and aromatase inhibitory evaluation of 4-N-nitrophenyl substituted amino-4H-1,2,4-triazole derivatives. Bioorg Med Chem Lett 2016;24:4723–30.
  • Zhao W, Zhou C, Guan ZY, et al. Structural insights into the inhibition of tubulin by the antitumor agent 4#–S–(1, 2, 4–triazole–3–yl)–podophyllotoxin. ACS Chem Biol 2017;12:746–52.
  • Timonen JM, Nieminen RM, Sareila O, et al. Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives. Eur J Med Chem 2011;46:3845–50.
  • Krishna C, Bhargavi MV, Rao CP, et al. Synthesis and antimicrobial assessment of novel coumarins featuring 1,2,4-oxadiazole. Med Chem Res 2015;24:3743–51.
  • Hamdy HA, Ahmed AEHH, Ahmed ENM, et al. Synthesis, reactions, antioxidant and anticancer evaluation of some novel coumarin derivatives using ethyl 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetate as a starting material. Eur J Med Chem 2014;5:111–21.
  • Liu JW, Pham PT, Skripnikova EV, et al. A ligand-based drug design. Discovery of 4-trifluoromethyl-7,8-pyranocoumarin as a selective inhibitor of human cytochrome P450 1A2. J Med Chem 2015;58:6481–93.
  • Eldehna WM, Almahli H, Al-Ansary GH, et al. Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosisinducing agents. J Enzyme Inhib Med Chem 2017;32:600–13.
  • Li N, Sun JY, Wang XJ, et al. Progress in bioactivities and synthetic methods of 4-arylcoumarins. Chin J Pharm 2015;46:1352–65.
  • Zhang WJ, Li Z, Zhou M, et al. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents. Bioorg Med Chem Lett 2014;24:799–807.